STLN

SEC source: 0001079973-26-001175 · ownership.xml · nonDerivative · entry 1

Hively Brad · CIK 0001891124 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 411,976

F1 · price: Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.37 to $6.75 per share. Upon request by the SEC, the Issuer or a stockholder of the Issuer, complete information regarding the number of shares sold at each price within the range will be provided.

SEC source: 0000921895-26-002203 · form414528003stln_08172026.xml · nonDerivative · entry 1

Chernett Jorey · CIK 0002042077 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,660,858

SEC source: 0000921895-26-002203 · form414528003stln_08172026.xml · derivative · entry 2

Chernett Jorey · CIK 0002042077 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2027-02-19

F1 · security: The sale of these call options is a matchable transaction subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer.

SEC source: 0001079973-26-000993 · ownership.xml · nonDerivative · entry 1

Kaushal Mohit · CIK 0001683021 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 205,716

F1 · kind: Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date.

SEC source: 0001079973-26-000989 · ownership.xml · nonDerivative · entry 1

Pacala Mark L · CIK 0001321250 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 286,881

F1 · kind: Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date.

SEC source: 0001079973-26-000991 · ownership.xml · nonDerivative · entry 1

McGeorge Anne · CIK 0001779934 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 332,535

F1 · kind: Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date.

SEC source: 0001079973-26-000987 · ownership.xml · nonDerivative · entry 1

STOLPER MARK · CIK 0001281961 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,957

F1 · kind: Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date.

SEC source: 0001079973-26-000983 · ownership.xml · nonDerivative · entry 1

Hively Brad · CIK 0001891124 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 710,829

F1 · kind: Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date.

SEC source: 0001079973-26-000985 · ownership.xml · nonDerivative · entry 1

TZOUMAKAS KIMBERLY JO · CIK 0001766666 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,301

F1 · kind: Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date.

SEC source: 0001079973-26-000981 · ownership.xml · nonDerivative · entry 1

Johnson Karen Marie · CIK 0001892819 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 319,410

F1 · kind: Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date.

SEC source: 0000921895-26-001852 · form414528003_07222026.xml · nonDerivative · entry 1

Chernett Jorey · CIK 0002042077 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,648,858

F1 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $5.27 to $5.28, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

SEC source: 0001553350-26-000111 · ownership.xml · derivative · entry 6

Podnos Yale · CIK 0001891104 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,478 shares

Expires 2034-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock options described above were originally granted on 11/17/2022 and 05/21/2024, respectively, and vested in accordance with their respective terms.

SEC source: 0001553350-26-000111 · ownership.xml · derivative · entry 5

Podnos Yale · CIK 0001891104 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,974 shares

Expires 2032-11-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock options described above were originally granted on 11/17/2022 and 05/21/2024, respectively, and vested in accordance with their respective terms.

SEC source: 0001553350-26-000111 · ownership.xml · nonDerivative · entry 4

Podnos Yale · CIK 0001891104 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 259,527

F1 · kind: The sale transactions were effected pursuant to a Rule 10(b) 5-1 trading plan adopted by the Reporting Person on 08/26/2025.

F3 · kind: The sales reported in Table I reflect shares acquired upon exercise of the options identified in Table II, sold on the same day pursuant to the 10(b) 5-1 plan referenced in Footnote 1.

SEC source: 0001553350-26-000111 · ownership.xml · nonDerivative · entry 3

Podnos Yale · CIK 0001891104 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 265,005

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001553350-26-000111 · ownership.xml · nonDerivative · entry 2

Podnos Yale · CIK 0001891104 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 259,527

F1 · kind: The sale transactions were effected pursuant to a Rule 10(b) 5-1 trading plan adopted by the Reporting Person on 08/26/2025.

F3 · kind: The sales reported in Table I reflect shares acquired upon exercise of the options identified in Table II, sold on the same day pursuant to the 10(b) 5-1 plan referenced in Footnote 1.

SEC source: 0001553350-26-000111 · ownership.xml · nonDerivative · entry 1

Podnos Yale · CIK 0001891104 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 277,501

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000921895-26-001798 · form414528001_07132026.xml · nonDerivative · entry 1

Chernett Jorey · CIK 0002042077 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,630,858

F1 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $5.82 to $5.90, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

SEC source: 0001079973-26-000940 · ownership.xml · nonDerivative · entry 1

TZOUMAKAS KIMBERLY JO · CIK 0001766666 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,185

F1 · kind: Represents RSU award that was fully vested upon grant

SEC source: 0001079973-26-000939 · ownership.xml · nonDerivative · entry 1

STOLPER MARK · CIK 0001281961 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,833

F1 · kind: Represents RSU award that was fully vested upon grant.

SEC source: 0000921895-26-001657 · form414528003_06242026.xml · nonDerivative · entry 1

Chernett Jorey · CIK 0002042077 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,615,858

F1 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $5.02 to $5.04, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

SEC source: 0001079973-26-000801 · ownership.xml · nonDerivative · entry 1

Podnos Yale · CIK 0001891104 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 259,527

F1 · kind: Price is the volume weighted average selling price of all sales on behalf of the Reporting Person on June 8, 2028 within a one-dollar range. Actual prices ranged from $5.35 to $5.42. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

F2 · kind: Sales were made on behalf of the Reporting Person pursuant to the Rule 10b5-1(c) plan that was adopted on 08/26/2025.

SEC source: 0000921895-26-001564 · form414528003_06052026.xml · nonDerivative · entry 1

Chernett Jorey · CIK 0002042077 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,579,858

SEC source: 0001079973-26-000723 · ownership.xml · nonDerivative · entry 1

Carter Robert Ross · CIK 0002039341 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 414,801

F1 · kind: The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award made on May 21, 2024.

SEC source: 0001079973-26-000727 · ownership.xml · nonDerivative · entry 1

Podnos Yale · CIK 0001891104 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 282,978

F1 · kind: The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award made on May 21, 2024.

SEC source: 0001079973-26-000725 · ownership.xml · nonDerivative · entry 1

Virnich Daniel · CIK 0001891107 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,337,166

F1 · kind: The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award made on May 21, 2024.

SEC source: 0000921895-26-001466 · form414528003_05212026.xml · nonDerivative · entry 2

Chernett Jorey · CIK 0002042077 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,567,858

F1 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $4.05 to $4.10, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

SEC source: 0000921895-26-001444 · form414528003toi_05202026.xml · nonDerivative · entry 1

Chernett Jorey · CIK 0002042077 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,529,358

SEC source: 0000921895-26-001466 · form414528003_05212026.xml · nonDerivative · entry 1

Chernett Jorey · CIK 0002042077 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,534,358

SEC source: 0001079973-26-000499 · ownership.xml · nonDerivative · entry 2

Kaushal Mohit · CIK 0001683021 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 172,583

F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 16, 2025.

F3 · price: Price of $3.5005 was the volume weighted average selling price of all sales by the reporting person on April 16, 2026 within a one-dollar range. Actual prices ranged from $3.5000 to $3.5050. The reporting person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

SEC source: 0001079973-26-000499 · ownership.xml · nonDerivative · entry 1

Kaushal Mohit · CIK 0001683021 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 211,016

F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 16, 2025.

F2 · price: Price of $3.5017 was the volume weighted average selling price of all sales by the reporting person on April 14, 2026 within a one-dollar range. Actual prices ranged from $3.5000 to $3.5300. The reporting person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

SEC source: 0000921895-26-000958 · form414528003_04132026.xml · nonDerivative · entry 1

Chernett Jorey · CIK 0002042077 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,499,358

SEC source: 0000921895-26-000823 · form414528003toi_03302026.xml · nonDerivative · entry 1

Chernett Jorey · CIK 0002042077 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,479,358

SEC source: 0001079973-26-000449 · ownership.xml · nonDerivative · entry 1

Langsam Jeffrey · CIK 0002069752 · Chief Clinical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 127,650

F1 · shares: Represents RSU awards with 1/4 of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.

SEC source: 0001079973-26-000440 · ownership.xml · nonDerivative · entry 2

Carter Robert Ross · CIK 0002039341 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 416,405

F2 · shares: The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award on March 31, 2026

SEC source: 0001079973-26-000440 · ownership.xml · nonDerivative · entry 1

Carter Robert Ross · CIK 0002039341 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 436,725

F1 · shares: Represents RSU awards with 1/4 of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.

SEC source: 0001079973-26-000443 · ownership.xml · nonDerivative · entry 2

Podnos Yale · CIK 0001891104 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 284,783

F2 · shares: The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award on March 31, 2026.

SEC source: 0001079973-26-000443 · ownership.xml · nonDerivative · entry 1

Podnos Yale · CIK 0001891104 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,956

F1 · shares: Represents RSU awards with 1/4 of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.

SEC source: 0001079973-26-000447 · ownership.xml · nonDerivative · entry 1

England Kristin · CIK 0002078090 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 153,780

F1 · shares: Represents RSU awards with 1/4 of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates

SEC source: 0001079973-26-000439 · ownership.xml · nonDerivative · entry 2

Virnich Daniel · CIK 0001891107 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,360,224

F2 · shares: The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award on March 31, 2026.

SEC source: 0001079973-26-000439 · ownership.xml · nonDerivative · entry 1

Virnich Daniel · CIK 0001891107 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,458,758

F1 · shares: Represents RSU awards with 1/4 of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.

SEC source: 0000921895-26-000814 · form414528003toi_03272026.xml · nonDerivative · entry 1

Chernett Jorey · CIK 0002042077 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,451,929

F1 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $3.11 to $3.19, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

SEC source: 0000921895-26-000796 · form414528003_03252026.xml · nonDerivative · entry 1

Chernett Jorey · CIK 0002042077 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,401,929

F1 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $3.04 to $3.15, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

SEC source: 0001193805-26-000306 · e665269_4-toi.xml · nonDerivative · entry 1

Chernett Jorey · CIK 0002042077 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,276,929

F1 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $3.33 to $3.35, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

SEC source: 0000921895-26-000712 · form414528003_03172026.xml · nonDerivative · entry 3

Chernett Jorey · CIK 0002042077 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,251,929

F3 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $3.39 to $3.49, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

SEC source: 0001079973-26-000330 · ownership.xml · nonDerivative · entry 1

Carter Robert Ross · CIK 0002039341 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 233,811

F1 · kind: The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award on March 17, 2026.

SEC source: 0001079973-26-000332 · ownership.xml · nonDerivative · entry 1

Virnich Daniel · CIK 0001891107 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,788,150

F1 · kind: The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award on March 17, 2026.

SEC source: 0001079973-26-000328 · ownership.xml · nonDerivative · entry 1

Podnos Yale · CIK 0001891104 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 234,510

F1 · kind: The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award on March 17, 2026.

SEC source: 0000921895-26-000712 · form414528003_03172026.xml · nonDerivative · entry 2

Chernett Jorey · CIK 0002042077 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,176,929

F2 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $3.25 to $3.43, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

SEC source: 0000921895-26-000712 · form414528003_03172026.xml · nonDerivative · entry 1

Chernett Jorey · CIK 0002042077 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,115,944

F1 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $2.77 to $3.34, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.